These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23884058)

  • 1. Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction.
    Schaefer M; Sarkar R; Diez-Quevedo C
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S111-7. PubMed ID: 23884058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.
    Freedman K; Nathanson J
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):363-76. PubMed ID: 19344248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
    Schaefer M; Heinz A; Backmund M
    Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
    Lang JP; Meyer N; Doffoel M
    Encephale; 2003; 29(4 Pt 1):362-5. PubMed ID: 14615706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse.
    Ho SB; Bräu N; Cheung R; Liu L; Sanchez C; Sklar M; Phelps TE; Marcus SG; Wasil MM; Tisi A; Huynh L; Robinson SK; Gifford AL; Asch SM; Groessl EJ
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):2005-14.e1-3. PubMed ID: 25724704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of disease in U.S. veteran patients with hepatitis C.
    Nguyen HA; Miller AI; Dieperink E; Willenbring ML; Tetrick LL; Durfee JM; Ewing SL; Ho SB
    Am J Gastroenterol; 2002 Jul; 97(7):1813-20. PubMed ID: 12135041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.
    Taylor LE; Schwartzapfel B; Allen S; Jacobs G; Mitty J
    Clin Infect Dis; 2003 Jun; 36(11):1501-2; author reply 1502-3. PubMed ID: 12766851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Managing psychiatric side effects of antiviral therapy in chronic hepatitis C].
    Schäfer A; Scheurlen M; Kraus MR
    Z Gastroenterol; 2012 Oct; 50(10):1108-13. PubMed ID: 23059806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.
    Quelhas R; Lopes A
    J Psychiatr Pract; 2009 Jul; 15(4):262-81. PubMed ID: 19625882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.
    Van Thiel DH; Friedlander L; Molloy PJ; Fagiuoli S; Kania RJ; Caraceni P
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):165-8. PubMed ID: 7712309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric implications of hepatitis-C infection.
    Giunta B; Somboonwit C; Nikolic WV; Rrapo E; Tan J; Shapshak P; Fernandez F
    Crit Rev Neurobiol; 2007; 19(2-3):79-118. PubMed ID: 19409058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widening the door: the evolution of hepatitis C treatment in patients with psychiatric disorders.
    Geppert CM; Arora S
    Hepatology; 2007 Oct; 46(4):957-9. PubMed ID: 17886300
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
    Hauser P
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.